-
1
-
-
0032555180
-
Neointimal tissue response at sites of coronary stenting in humans: Macroscopic, histological, and immunohistochemical analyses
-
R. Komatsu, M. Ueda, T. Naruko, A. Kojima, and A.E. Becker Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses Circulation 98 1998 224 233
-
(1998)
Circulation
, vol.98
, pp. 224-233
-
-
Komatsu, R.1
Ueda, M.2
Naruko, T.3
Kojima, A.4
Becker, A.E.5
-
2
-
-
13344293686
-
Three-year follow-up after implantation of metallic coronary-artery stents
-
T. Kimura, H. Yokoi, and Y. Nakagawa Three-year follow-up after implantation of metallic coronary-artery stents N Engl J Med 334 1996 561 566
-
(1996)
N Engl J Med
, vol.334
, pp. 561-566
-
-
Kimura, T.1
Yokoi, H.2
Nakagawa, Y.3
-
3
-
-
33847766568
-
Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents
-
A. Kastrati, J. Mehilli, and J. Pache Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 1030 1039
-
(2007)
N Engl J Med
, vol.356
, pp. 1030-1039
-
-
Kastrati, A.1
Mehilli, J.2
Pache, J.3
-
4
-
-
24644465504
-
Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent
-
R. Wessely, A. Kastrati, and A. Schömig Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent Ann Intern Med 143 2005 392 394
-
(2005)
Ann Intern Med
, vol.143
, pp. 392-394
-
-
Wessely, R.1
Kastrati, A.2
Schömig, A.3
-
5
-
-
33748079468
-
Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials)
-
T.T. Lee, L. Feinberg, and D.S. Baim Effect of diabetes mellitus on five-year clinical outcomes after single-vessel coronary stenting (a pooled analysis of coronary stent clinical trials) Am J Cardiol 98 2006 718 721
-
(2006)
Am J Cardiol
, vol.98
, pp. 718-721
-
-
Lee, T.T.1
Feinberg, L.2
Baim, D.S.3
-
6
-
-
33847705701
-
Stent thrombosis in randomized clinical trials of drug-eluting stents
-
L. Mauri, W.H. Hsieh, J.M. Massaro, K.K.L. Ho, R. D'Agostino, and D.E. Cutlip Stent thrombosis in randomized clinical trials of drug-eluting stents N Engl J Med 356 2007 1020 1029
-
(2007)
N Engl J Med
, vol.356
, pp. 1020-1029
-
-
Mauri, L.1
Hsieh, W.H.2
Massaro, J.M.3
Ho, K.K.L.4
D'Agostino, R.5
Cutlip, D.E.6
-
7
-
-
34548851431
-
Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era
-
R. Iijima, G. Ndrepepa, and J. Mehilli Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era Am Heart J 154 2007 688 693
-
(2007)
Am Heart J
, vol.154
, pp. 688-693
-
-
Iijima, R.1
Ndrepepa, G.2
Mehilli, J.3
-
8
-
-
33847167065
-
Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: Data from a large two-institutional cohort study
-
J. Daemen, P. Wenaweser, and K. Tsuchida Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study Lancet 369 2007 667 678
-
(2007)
Lancet
, vol.369
, pp. 667-678
-
-
Daemen, J.1
Wenaweser, P.2
Tsuchida, K.3
-
9
-
-
39849098745
-
ESTROFA Study Group. Drug-eluting stent thrombosis: Results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos)
-
J.M. de la Torre-Hernández, F. Alfonso, and F. Hernández ESTROFA Study Group. Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos) J Am Coll Cardiol 51 2008 986 990
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 986-990
-
-
De La Torre-Hernández, J.M.1
Alfonso, F.2
Hernández, F.3
-
10
-
-
70349896556
-
Stent thrombosis after drug-eluting stent implantation: Incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period
-
S. Schulz, T. Schuster, and J. Mehilli Stent thrombosis after drug-eluting stent implantation: incidence, timing, and relation to discontinuation of clopidogrel therapy over a 4-year period Eur Heart J 30 2009 2714 2721
-
(2009)
Eur Heart J
, vol.30
, pp. 2714-2721
-
-
Schulz, S.1
Schuster, T.2
Mehilli, J.3
-
11
-
-
64749101214
-
Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer
-
R.A. Byrne, R. Iijima, and J. Mehilli Durability of antirestenotic efficacy in drug-eluting stents with and without permanent polymer JACC Cardiovasc Interv 2 2009 291 299
-
(2009)
JACC Cardiovasc Interv
, vol.2
, pp. 291-299
-
-
Byrne, R.A.1
Iijima, R.2
Mehilli, J.3
-
12
-
-
77955469156
-
J-Cypher Registry Investigators. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry)
-
Y. Nakagawa, T. Kimura, and T. Morimoto j-Cypher Registry Investigators. Incidence and risk factors of late target lesion revascularization after sirolimus-eluting stent implantation (3-year follow-up of the j-Cypher Registry) Am J Cardiol 106 2010 329 336
-
(2010)
Am J Cardiol
, vol.106
, pp. 329-336
-
-
Nakagawa, Y.1
Kimura, T.2
Morimoto, T.3
-
14
-
-
10744229988
-
Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: Should we be cautious?
-
R. Virmani, G. Guagliumi, and A. Farb Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 109 2004 701 705
-
(2004)
Circulation
, vol.109
, pp. 701-705
-
-
Virmani, R.1
Guagliumi, G.2
Farb, A.3
-
15
-
-
79952414020
-
The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents
-
G. Nakazawa, F. Otsuka, and M. Nakano The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents J Am Coll Cardiol 57 2011 1314 1322
-
(2011)
J Am Coll Cardiol
, vol.57
, pp. 1314-1322
-
-
Nakazawa, G.1
Otsuka, F.2
Nakano, M.3
-
16
-
-
84861371093
-
Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: A pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials
-
G.G. Stefanini, R.A. Byrne, and P.W. Serruys Biodegradable polymer drug-eluting stents reduce the risk of stent thrombosis at 4 years in patients undergoing percutaneous coronary intervention: a pooled analysis of individual patient data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS randomized trials Eur Heart J 33 2012 1214 1222
-
(2012)
Eur Heart J
, vol.33
, pp. 1214-1222
-
-
Stefanini, G.G.1
Byrne, R.A.2
Serruys, P.W.3
|